Susan Lane Stone Email & Phone Number

United States

Responsible for overseeing all aspects of the National Headache Foundation's operations.Through community engagement, we strive to improve the lives of individuals through building awareness, delivering evidence-based education, funding research, and inspiring advocacy with and for each of the over 40 million Americans. Innovation in timely diagnosis, treatments and access to care models will alleviate the pain and suffering from headache and migraine, and improve quality of life in households across our country.

Focus on 4 pillars: Awareness – Increase public awareness regarding headache disorders and the impact on the individual, their families, and society. Advocacy-Represent people living with headache disorders in efforts with insurance providers, and governmental agencies. Education- Providing information to patients, healthcare professionals, and the media. Research – Support into potential headache causes and treatments

Build and execute client strategy that delivers meaningful growth and exceeds expectations for healthcare consumers.For Profit Clients: B2B2C strategic advisor enterprise-wide from Clinical Discovery, Development to GTM access planning, development, and execution. Ensuring Patient Access and Choice to meaningful solutions to unmet needs that matter through (1) Clinical Patient & Prescriber Adoption Playbooks, (2) Coding, Coverage, Payment, (3) Customer Service (4) Development of marketing, communications, and advocacy planning and programs. • Coordinating strategy across business channels: patients, providers and medical groups, clinical practice setting bodies, payers, policymakers and the regulatory bodies. • Executing phased strategy in targeted customers to achieve scale, such as: Tech-enabled primary care groups, Specialty GPOs, VA/DoD, IDNs, ACOsExperience: Mental Health/SUD/OUD (6 years); Migraine (13 years), CNS (12 years); Women’s Health (16 years) Gastroenterology (18 years), Urology (14 years), Breast Health (12 years), Eyecare (14 years), Dermatology (10 years) Non-Profit Clients: Strategic planning, development, and marketing coordination to elevate visibility that aligns and supports the mission of education, advocacy, and programs that make a difference in people’s lives.

Focus on preventing blindness and preserving sight. Providing professional training and technical assistance to almost 7MM; and serving 1.2MM children and adults with direct eye health services.

Boston, Massachusetts, United States

Prescription Digital Therapeutics (PDTs): 3 FDA cleared-first to market in SUD/OUD/Insomnia. Created new functional department to support sales, marketing, market access, government affairs GTM strategy execution. Hired and mentored my team of three 9-month term Interns who supported the new advocacy connections of over 35 organizations that included: Provider Medical Associations, Federal Agencies, State Mental Health Policy Coalitions, The National Council on Mental Well Being (3,100 sites; 10M+ patients), National Women’s Health Resource CenterPurpose: Education and Awareness leading to action FOR (1) coding, coverage, payment, (2) provider and patient adoption of Pear products. Developed and operationalized programs: Identification and deployment of best advocacy messengers to champion need for clinically-validated PDTs that deliver evidence-based CBT, Contingency Management, and Fluency training in support of serious mental health, substance and opioid use disorders. Designed & launched inaugural patient engaged ACTION for PDTs at AIMED Alliance 501c3 -Washington DC.

Biopharma & Medical Devices in: CNS, Mental Health, Migraine, Eye Care, Women’s Health, Urology, GI - IBS, NASH, Obesity, Breast Health, Aesthetics. Blockbuster Brands: VRAYLAR for MDD, Bipolar; BOTOX Therapeutic for CNS, Chronic Migraine, OABLed team of 6 plus 12 agencies, partnered across a heavily matrixed environment; in the creation of a global hub, and leadership decision making seat at the table with all inline and pipeline development, product launch teams. Member of corporate global leadership team (Top 1% of company). • Tasked with developing and launching meaningful global patient centricity and advocacy systems, processes, and messaging continuity while honoring and celebrating all differences; US plus nine ex-US must-win countries. Patient engagement with drug/clinical development, medical affairs, and commercial.o Member of the Rapid Response Team—leading advocacy during textured Breast Implant recall effort• Embedded co-creation of communication tools and resources enterprise-wide for both inline and pipeline medicines-focusing on patient insights, patient personas, patient support services, and innovative digital solutions.  Global and broad multi-channel inclusion of optimal partners - healthcare professionals, patients, caregivers, consumer influencers, networks/coalitions, labor, employers, multi-cultural, veterans, and policymakers-50+ advisory thought leaders/C-Suite executives.• Coordinated the global advocacy work-streams across the product lifecycle of all Allergan medicines and medical deviceso Coordination of advocacy inputs for patient centricity portal, patient journey mapping, trial protocol co-design, patient literate communications, ICER readiness and deployment, and regulatory activations. o Designed and operationalized corporate patient centricity into global DNA across 400+ external third-party stakeholders.

Tasked with US enterprise-wide design, development and training across 16+ internal functional departments and 300+ external non-profit organizations. Accountable for advocacy for all inline and pipeline medicines. Led team, agencies of record, and multiple internal stakeholder departments in elevating advocacy relations from transactional decentralized access into a transformational hub resulting in surround sound patient engagement/centricity experiences.  Selected as lead to align, coordinate, build bridges, and elevate disparate corporate alliance advocacy services and relationships for over 22 acquired companies (in 4-year period) across 15+ therapeutic areas merged under one unified Allergan culture – BOLD for Life. Executed comprehensive FDA draft guidance protection Advocacy campaign (2013 – 2018) to support #1 Eye Asset securing over 1,000 advocacy stakeholder touchpoints, resulting in FDA reconsidering direction.  Collaboration with Neuro Migraine Brand Team with the creation of the annual Migraine Innovation Navigation Discovery ((MIND) Summit 11 patient migraine leaders Coordinated Eyecare Events: (1) E3 and (2) Strategic Vision Workshop – Patient and Caregiver Insights track. Led development, launch, training for new Alliance Support (ASMES) online grant program in 2017 Employee Engagement: Led launch of 15 custom charity activations at 8 US corporate sites, resulted in doubling the number of attendees, and provided closer linkage to the patients we serve.

Led activation of advocacy campaigns and engaged 200+ external stakeholders to ensure unencumbered, affordable access to appropriate Allergan therapies and medical devices, considering healthcare reform and other evolving policies.  Collaborated to maintain and expand favorable public policies, while supporting product integrity of distribution channels.  Designed and operationalized innovative advocacy campaigns with government affairs, regulatory, and commercial payer teams to ensure appropriate patient has timely access to appropriate Allergan medicines. Gained HCP access to BOTOX therapeutic at VA by leading VISN strategy and communication plans. Secured approval of products with buying groups in long-term care settings, for products focused on urology, Alzheimer’s, and mental health.  Championed passage of CA-AB2418- eye drop refills, and SB600 – product integrity by designing and executing advocacy campaigns in coordination with Allergan state lobbyists and thought leader influencers.

Ensured access and choice to Allergan medicines in Public and Private Payers for seven states (TX, OK, AR, LA, CO, NM, and UT) for Allergan portfolio of products in eye care, neurosciences, urology, dermatology, breast reconstruction, and bariatric surgery. Educated and activated initiatives of Affordable Care Act. Designed and developed innovative technology database for identifying, training, and deploying interested KOL advocates in support of unencumbered access, choice, and fair reimbursement for patients they serve. Protected formulary status by securing testimony from Allergan and appropriate number of interested external advocate stakeholders during PDL efforts by management like Provider Synergies. Implemented corporate policy strategy for continuing implementation of MMA 2003 with consolidation of Medicare Administrative Contractors (MACs), and commercial payer team as Medicare Advantage and Managed Medicaid plans mobilized.

Allergan Corporate Coordinating Liaison 8/2010-6/2020The Allergan Foundation focuses its support on charitable efforts dedicated to promoting access to quality healthcare and improving patient diagnosis, treatment, care and quality of life. Established in 1998, The Allergan Foundation has donated approximately $108 million to a wide variety of philanthropic pursuits globally.

Supported innovator oncology biotech startups – P2/P3, regulatory, market access, and product launch strategy to position for success in identifying network partners.

Led healthcare policy and reimbursement team of 10 in management/development of Medicare Part B and Medicaid across 28 states, representing $1.2B in sales for physician injected medicines in oncology, nephrology, and immunology. Collaborated with payer training of sales organization in markets for PROCRIT, DOXIL, and ORTHOVISC.  Coordination of HCP, patient, policy organizations providing advocacy voices for access & choice

Western Us

Led business initiatives for OBI products valued at $500M for key national accounts-GPOs/IDNs, Physician Networks (US Oncology, Novation, Broadlane, Owen) and commercial payers-MCOs/PPOs (Kaiser, BCBS, UHC/Pacificare, Aetna, Cigna, Humana, HealthNet).  Drove profitable growth of Procrit from $80M to $250M in U.S. oncology market through 27 states and 850+ oncologists, by developing and implementing strategy and tactics.

Master Of Business Administration (Mba), International Business

Completed MBA

Master Of Business Administration (Mba), International Management

Began MBA

Bs, Marketing, Advertising